Why Black American Women Are Flying to South Korea for the Healthcare They Can’t Get at Home

⏱ 17 min read

This piece summarizes reporting and published data on medical tourism. Individual cases are drawn from public reporting; specific names and institutions have been generalized. It is informational and not medical advice. Anyone weighing care abroad should consult licensed medical professionals.

Why Black women are choosing medical tourism in South Korea

Americans crossing borders for cheaper care is an old story. Dental work in Mexico, prescription drugs in Canada, hair transplants in Turkey. But one destination has been rising quietly, and what a growing number of Black American women go there for is not cosmetic. It is Seoul, and the reason is Black women medical tourism South Korea has come to represent something the U.S. system rarely offers them: care that feels thorough, fast, and respectful.

In a July 2026 report, The Guardian interviewed several Black American women who told nearly the same story. They felt minimized or dismissed at home. In Korea, for the first time, they felt treated as a whole patient.

South Korea is known as the world capital of cosmetic dermatology and plastic surgery. What these women found was something else. Comprehensive preventive screening, broad diagnostic testing, and care that costs less and moves faster than in the United States. This article lays out why the pattern is happening, what the data says, and what it means for anyone who has ever felt rushed through a doctor’s office.

What they wanted: to know what is actually happening in their body

A preventive-health platform that connects American clients with Korean screening centers reports that requests from Black American women have risen sharply over the past few years. The pattern is specific. What they want is not cosmetic. It is diagnostic. Gynecological, thyroid, and cardiovascular screening.

The tests they ask for most are not random. They line up almost exactly with the conditions where Black women in the United States face the widest disparities and the most documented gaps in clinical attention.

Consider one case from the reporting. A 36-year-old nonprofit worker from Washington visited a Seoul screening center in April.

Morning, screening begins. She had a checkup every year in the United States and a good relationship with her medical team. She did not expect a problem.

Ultrasound. During the comprehensive exam, an ultrasound found a 10cm uterine fibroid. She had no idea it was there.

Minutes later, MRI. It was confirmed on the spot with an MRI. She described the process as simple rather than frustrating.

Screening ends. The full comprehensive checkup came to just under 600 dollars.

She had a checkup every year and still did not know. That one sentence holds the center of this story. For a woman who never missed an annual exam, the standard U.S. checkup still missed the fibroid.

What was different from the U.S.: being treated as a patient

Many Black women describe having their symptoms minimized or dismissed inside the U.S. system. So they learn to become their own advocates. They push for extra testing and specialist referrals, seek second opinions, and walk into appointments armed with knowledge about their own condition just to be taken seriously.

A 42-year-old brand strategist quoted in the reporting described the U.S. experience as feeling rushed, unheard, and short on time to give the full picture. If she did not organize her notes and say everything in one breath, she felt she would not get the attention she needed.

She wears a wig because of hair loss from alopecia. During U.S. appointments, removing it drew looks and comments. In Korea, no one judged. She said she felt no prejudice, felt heard, and felt understood.

This is not only a difference in manner. It is a difference in system design. U.S. care is built around intervention, structured for acute and episodic problems. Korean care is built around catching problems before they become emergencies. Preventive screening is woven into the culture. Employers sponsor it, the government subsidizes it for citizens, and clinics are purpose-built around the checkup itself. It is not a system for the sick. It is a system for confirming the baseline of people who are not yet sick.

Why this group: what the data says about the disparity

Here is where the story goes a step past the personal. Why Black women want these specific screenings is not a matter of feeling. It is a matter of data.

Start with blood pressure. According to the American Heart Association, high blood pressure affects 59.2% of non-Hispanic Black women, one of the highest prevalence rates in the world. Yet only about 22%, roughly 1 in 5, have it under control. CDC data also shows hypertension prevalence is highest among Black men and women among all racial groups.

Cardiovascular disease is the leading cause of death among Black American women. Even so, studies find they are more likely to experience delays in diagnosis and treatment.

Uterine fibroids follow the same shape. Fibroids show higher prevalence, earlier onset, and greater severity in Black women than in white women, according to a systematic review in Fertility and Sterility. And Black women are more likely to have symptoms dismissed and to see a specialist too late, which delays diagnosis and treatment, per Michigan Medicine. The diagnostic tools themselves carry gaps. Ultrasound-based diagnosis of endometrial cancer is less accurate in Black women, producing more false negatives, and in 2026 the American College of Obstetricians and Gynecologists updated its guidance to correct that racial disparity.

Insurance compounds it. Black Americans are 1.5 times as likely to be uninsured as white Americans, according to KFF. Insured or not, the wall between them and the test they need stands higher.

Put in numbers, the picture sharpens. A Korean one-day comprehensive screening bundles cardiovascular imaging, thyroid ultrasound, gynecological screening, bloodwork, and specialist review into a single visit. That bundle maps precisely onto the conditions where Black women in the U.S. face the widest gaps. It is not a coincidence. It is a structural match.

Why early detection changes everything

When a condition is found changes the outcome. This is not sentiment. It is survival data.

Take breast cancer. Caught at a localized stage, the 5-year relative survival rate is about 99%. Found after it has spread to distant sites, it falls to roughly 23% to 31%, per peer-reviewed cancer registry data. Lung cancer shows an even wider gap. Stage 1 runs about 60%, stage 4 about 5%. Ovarian cancer survival exceeds 90% when caught early, but only about 20% of cases are found at an early stage.

The 10cm fibroid that the 36-year-old found in a single morning is not cancer. But the principle is identical. Confirm the baseline while there are no symptoms, and catch the problem before it grows. That is the whole of preventive screening. The weight of this story is that something a yearly-checkup patient kept missing was caught in one comprehensive exam.

Why South Korea is this fast and this precise

How does a jump from ultrasound to confirming MRI happen in minutes on the same morning? The answer lies in equipment and in the sheer volume of repetition.

Start with equipment. According to the OECD’s Health at a Glance 2025, Korea has 87 CT, MRI, and PET scanners per million people combined, well above the OECD average of 51. It has 12.6 hospital beds per 1,000 people, three times the OECD average of 4.2. Where a U.S. patient waits 2 to 3 weeks for an MRI slot, Korea has enough machines that same-day imaging is the standard, not the exception.

The numbers behind the gap: who actually gets screened

Participation percentages alone do not land. Put the raw population and the ratio side by side, and the volume gap becomes clear.

Korea. The National Health Insurance Service provides a general health screening to every adult 40 and older, every two years, and every year for manual workers. Participation among the eligible population was about 75.9% in 2023, and national cancer-screening participation was 59.8%. With a population near 52 million and a system that covers the entire adult population, tens of millions of screenings repeat every year. The gastric endoscopy component alone ran roughly 7.76 million exams in a single year, per the Journal of the Korean Medical Association.

United States. There is no national comprehensive-screening system. People arrange annual wellness visits or preventive screenings individually, and the gaps are wide. About 1 in 4 adults say they skip routine checkups simply because they feel healthy, and roughly half report avoiding at least one common screening, according to a national wellness survey. About 1 in 5 Black and Hispanic adults had no checkup at all in the past year. Even among Medicare enrollees, only 45% had an annual wellness visit in 2020, per CMS.

The two are not the same product, and it is worth saying plainly. Korea’s screening is a bundle of real tests: bloodwork, imaging, and age-based cancer screening including endoscopy. The U.S. annual wellness visit is largely questionnaire and counseling, with endoscopy, ultrasound, and MRI ordered separately. The same word, screening, means a test bundle in one country and scattered pieces in the other.

As a ratio: in Korea, 3 of every 4 eligible adults (75.9%) actually go through the test bundle. In the U.S., 1 in 4 adults skips the checkup entirely, half avoid at least one screening, and even seniors sit at a 45% wellness-visit rate. If that questionnaire-based visit alone runs that low, the share reaching a Korea-style test bundle runs far lower.

The real U.S. barrier: the door to testing is closed by default

Here is the point that stings most for American readers. In the United States, you cannot simply get a test because you want one.

Diagnostic imaging like ultrasound, MRI, and CT generally requires a physician to order it on grounds of medical necessity. Then insurance reviews that necessity again. Diagnostic imaging for asymptomatic people is, as a rule, not covered. Medicare policy states that diagnostic imaging for asymptomatic persons is not covered, and that every billed diagnostic service must name the specific symptom or sign that makes it necessary.

Private insurers add another gate called prior authorization. Even after a doctor orders imaging, the insurer must accept the necessity based on symptoms and history before it will pay. Get it without approval, and the full cost falls on the patient. Some large insurers deny more than 30% of MRI requests, per imaging-appeal analyses. Routine screening with no symptoms rarely clears approval unless age or risk criteria are met.

So the U.S. logic runs like this. You need symptoms to reach a test. But like that 36-year-old’s 10cm fibroid, many conditions grow quietly before any symptom appears. No symptoms means no order, no order means no test, and no test means late detection. Late detection, as the survival data showed, means lower survival and more invasive, more expensive treatment. The closed door itself produces the delay.

Korea’s screening culture inverts that logic. No symptoms and no physician order required. If you want a comprehensive screening, you book it. That is the starting point of prevention: a person who is not yet sick confirming the baseline of their own body. That difference is exactly why a woman who never missed a U.S. checkup found her fibroid in one Seoul morning.

Same test bundle: assembled in the U.S., done in one visit in Korea

Take the components of the roughly 600-dollar screening that the 36-year-old received in Seoul, and price each one out separately in the United States. U.S. figures below are uninsured cash prices.

In the United States, these tests are not in one place. Bloodwork at a lab, ultrasound at an imaging center, endoscopy at a GI practice, MRI at yet another facility. Each is booked separately, waited for separately, and billed separately. Add the specialist waits (OB/GYN 41.8 days, gastroenterology 40 days, cardiology 32.7 days), per the AMN Healthcare 2025 survey, plus the 2-to-3-week MRI wait, and completing the whole bundle takes weeks to months. Summed at cash prices, it reaches thousands of dollars for the uninsured.

Korea folds all of it into one screening center in half a day. Dedicated screening chains bundle blood, urine, chest imaging, ultrasound, endoscopy, and ECG as the base package, with MRI and genetic testing as add-ons. A basic comprehensive screening runs roughly 350 to 600 dollars, and a higher-tier package with endoscopy and imaging runs about 900 to 2,200 dollars, per published Korean checkup guides. When the pelvic ultrasound shows something, the MRI that would take 2 to 3 weeks in the U.S. is done in minutes on the spot.

Now the volume and the skill connect. Enough equipment, near-universal national participation, and rapidly rising foreign checkup experience. In 2025, Korea drew 2.01 million foreign patients, up from the 600,000-range in 2023, and U.S. patients reached 173,363, a 70.4% jump, per Korea’s Ministry of Health and Welfare. Telling detail: in 2024, Americans came for health checkups (11,780) more than for plastic surgery (11,250), and checkups grew to 15,695 in 2025. The center of gravity for U.S. visitors is shifting from cosmetic to diagnostic. The speed and precision those patients felt in Seoul is not a stroke of kindness. It is the skill that volume builds over time.

Black women medical tourism South Korea: not hope, but data

A fair question arises. Is this just a satisfying anecdote, or does it actually change outcomes?

There is data. In a study published in BMC Cancer by the University of Washington and the Fred Hutchinson Cancer Center, people who traveled abroad for lower-cost care were 8.91 times as likely to be up to date on colorectal cancer screening as those who did not. Medical tourism was the single strongest predictor of screening currency in that group, per the University of Washington School of Public Health. Screening abroad measurably lifts the odds of early detection.

Korea’s national cancer-screening record backs it up. Gastric cancer 5-year relative survival rose from 43.9% in 1993 to 1995 to 77.5% in 2015 to 2019, early-detection share climbed from 28.6% to 63.6%, and the risk of death from gastric cancer fell 47% among those screened by endoscopy. Korea’s gastric cancer survival is more than double that of the United States. Much of that gap comes from a screening-first system.

The same principle applies to the foreigner who comes to be screened. Catch it earlier, and the outlook improves, the treatment is less invasive, and the cost drops.

What it costs and who pays: detection is only the start

Here is the part many people miss. In the United States, the barrier is less the detection than what comes after it.

Say something turns up on a screen. Next comes the specialist appointment. Then, if surgery is needed, the bill. For a fibroid confirmed for surgery, an uninsured myomectomy runs roughly 11,000 to 22,000 dollars, uterine artery embolization roughly 10,000 to 15,000 dollars, and an uncomplicated hysterectomy or myomectomy has been reported as high as 42,000 dollars, per GoodRx Health. Black women are also more likely to be steered toward hysterectomy or larger-incision procedures rather than less invasive options, in part because fibroids are often found only after they have grown large. Late detection leads to more invasive treatment and higher cost.

Against that contrast, the meaning of the Korean model is clear. From detection to confirmation in minutes on the same day. If treatment is needed, at a fraction of U.S. cost. Real cost-comparison case files from Korea show how this plays out for specific procedures, from HER2 breast cancer treatment to joint replacement.

The balance: medical tourism is not a cure-all

One part deserves an honest note. Care abroad remains a privilege reserved for the relatively small share of Americans with the money and flexibility to travel. It does nothing to fix the structural inequities that produce disparities in Black women’s health in the first place. Follow-up care still has to continue back home. When something is found on a screen, continuity with a home medical team matters for treatment.

The rise of Black women medical tourism to South Korea is not the answer to fixing the system. Even so, the women interviewed all planned to return to Korea for routine checkups. What stayed with them was not only the care or the price. It was the experience of being respected in a medical setting.

In the end, this is everyone’s story

The pattern is about Black women, but the problem they found is not theirs alone. The rushed visit, the dismissed symptom, the burden of becoming your own advocate, the wait and the cost after detection. Anyone who has been through the U.S. system will recognize it, across gender and race.

What these women found in Korea was a simple idea. Prevention. Catching a problem before it becomes an emergency. And knowing the baseline of your own body. The line one of them left behind stays with you. A trip to Korea will be fun and memorable, but it could also literally save your life.

This is what it looks like to take care of yourself when the system will not do it for you. In the next installment, we compare what these screenings actually include, where, and for how much, country by country: Thailand, Malaysia, and beyond, alongside the data on cancer survival by country and what happens when people skip care because of cost.

This article is for informational and educational purposes only and does not constitute medical advice. It does not replace consultation with a qualified healthcare professional. Screening decisions, care abroad, and treatment choices should be made with licensed medical providers who know your history. This is a sensitive area of health and cost. If you are weighing care because of cost or access barriers, a licensed clinician or patient-advocacy resource can help you evaluate your options.

Thanks for reading. Take care of yourself. Nobody else will do it for you.